OleanderPhoenix raises >$3,000,000 from angel investors. Posted on July 2008June 2022 by Carlos Torres 06 Jul Publication: Cardiac glycosides as novel cancer therapeutic agents. Newman RA, Yang P, Pawlus AD, Block KI. Mol Interv. Phoenix Biotechnology executes a second amendment to its Sponsored Research Agreement with M. D. Anderson Cancer Center.
